Abstract
An approach to carboplatin dosing in children with bilateral nephrectomy using a renal function-based dosing formula with a glomerular filtration rate of zero was investigated in the current study. Carboplatin exposure was determined in a total of nine courses of chemotherapy in four patients with Wilms’ tumour. Carboplatin exposures following initial dosing were less than 50% of the defined target area under the plasma concentration-time curve (AUC) in all four patients studied, with actual AUC values of between 31% and 45% of the target exposures. The use of real-time pharmacokinetic monitoring to guide dosing within a course of carboplatin treatment resulted in exposures within 15% of the target AUC in all patients. Using this information to guide dosing on additional courses of treatment in the same patient resulted in consistent exposures without the need for further monitoring or dose adjustment. These results indicate that real-time pharmacokinetic monitoring of carboplatin treatment plays a key role in ensuring that an appropriate exposure to carboplatin is achieved in children with bilateral nephrectomy. Carboplatin dosing based on patient body weight, or use of a fixed dose of carboplatin, would both be predicted to result in individual patients receiving unsatisfactory drug exposures. Further studies are warranted to further elucidate the relationship between non-renal clearance of carboplatin and patient body weight in this and other patient subpopulations where there remains concern about the optimal way to use this anticancer drug.
Similar content being viewed by others
References
English MW, Lowis SP, Peng B, Newell DR, Price L, Pearson ADJ (1996) Pharmacokinetically guided dosing of carboplatin and etoposide during peritoneal dialysis and haemodialysis. Br J Cancer 73:776
Gaynon PS (1994) Carboplatin in pediatric malignancies. Semin Oncol 21[Suppl 12]:65
Jodrell DI, Egorin MJ, Canetta RM, Langenberg P, Goldbloom EP, Burroughs JN, Goodlow JL, Tan S, Wiltshaw E (1992) Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer. J Clin Oncol 10:520
Koren G, Weitzman S, Klein J, Moselhy G (1993) Comparison of carboplatin pharmacokinetics between an anephric child and two children with normal renal function. Med Pediatr Oncol 21:368
Kudelka AP, Siddik ZM, Balat O, Kavanagh JJ (1995) Carboplatin dosimetry in renal failure. J Clin Oncol 13:2147
Madden T, Sunderland M, Santana VM, Rodman JH (1992) The pharmacokinetics of high-dose carboplatin in pediatric patients with cancer. Clin Pharmacol Ther 51:701
Marina NM, Rodman JH, Murry DJ, Sheman SJ, Bowman LC, Jones PP, Furman WL, Meyer WH, Pratt CB (1994) Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in newly diagnosed pediatric solid tumors. J Natl Cancer Inst 86:544
Newell DR, Siddik ZH, Gumbrell LA, Boxall FE, Gore ME, Smith IE, Calvert AH (1987) Plasma free platinum pharmacokinetics in patients treated with high dose carboplatin. Eur J Cancer Clin Oncol 23:1399
Newell DR, Pearson ADJ, Balmanno K, Price L, Wyllie RA, Keir M, Calvert AH, Lewis IJ, Pinkerton CR, Stevens MC (1993) Carboplatin pharmacokinetics in children: the development of a pediatric dosing formula. J Clin Oncol 11:2314
Thomas HD, Boddy AV, English MW, Hobson R, Imeson J, Lewis I, Morland B, Pearson ADJ, Pinkerton R, Price L, Stevens M, Newell DR (2000) Prospective validation of renal function-based carboplatin dosing in children with cancer: a United Kingdom Children’s Cancer Study Group trial. J Clin Oncol 18:3614
Veal GJ, Foot A, McDowell H, Ellershaw C, Pearson ADJ, Boddy AV (2002) Optimization of high dose carboplatin treatment in children with stage IV soft tissue sarcoma (SIOP/UKCCSG MMT 98 study) by real-time pharmacokinetic monitoring. Proc Am Assoc Cancer Res 43:1364
Acknowledgements
This work was supported by funding from Cancer Research UK.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Veal, G.J., English, M.W., Grundy, R.G. et al. Pharmacokinetically guided dosing of carboplatin in paediatric cancer patients with bilateral nephrectomy. Cancer Chemother Pharmacol 54, 295–300 (2004). https://doi.org/10.1007/s00280-004-0820-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00280-004-0820-3